Monitoring post-translational modification of proteins with allosteric ribozymes

被引:47
作者
Vaish, NK
Dong, F
Andrews, L
Schweppe, RE
Ahn, NG
Blatt, L
Seiwert, SD
机构
[1] Ribozyme Pharmaceut Inc, Boulder, CO 80301 USA
[2] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA
关键词
D O I
10.1038/nbt719
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
An allosteric hammerhead ribozyme activated specifically by the unphosphorylated form of the protein kinase ERK2 was created through a rational design strategy that relies on molecular recognition of ERK2 to decrease the formation of an alternate, inactive ribozyme conformer. Neither closely related mitogen-activated protein kinases (MAPKs) nor the phosphorylated form of ERK2 induced ribozyme activity. The ribozyme quantitatively detected ERK2 added to mammalian cell lysates and also functioned quantitatively in a multiplexed solution-phase assay. This same strategy was used to construct a second ribozyme selectively activated by the phosphorylated (active) form of ERK2. This approach is generally applicable to the development of ribozymes capable of monitoring post-translational modification of specific proteins.
引用
收藏
页码:810 / 815
页数:6
相关论文
共 42 条
[41]   Interaction of U2AF(65) RS region with pre-mRNA of branch point and promotion base pairing with U2 snRNA [J].
Valcarcel, J ;
Gaur, RK ;
Singh, R ;
Green, MR .
SCIENCE, 1996, 273 (5282) :1706-1709
[42]   Selection, design, and characterization of a new potentially therapeutic ribozyme [J].
Zinnen, SP ;
Domenico, K ;
Wilson, M ;
Dickinson, BA ;
Beaudry, A ;
Mokler, V ;
Daniher, AT ;
Burgin, A ;
Beigelman, L .
RNA, 2002, 8 (02) :214-228